æqualis logo

Clinical-Grade Synthetic Data for Surgical & Oncology Innovation

In March 2026, æqualis was selected for a 2-year intensive acceleration program at Inova UFMG (Federal University of Minas Gerais). This partnership ensures our synthetic data generation adheres to the highest academic and ethical standards in AI development.

Finalist at the 2025 “Juntos Inovamos.Coop” program. Recognized among the top healthcare startups for AI-driven patient simulation.

  • Avoids risks tied to personal health data (PHI)
  • Ready for AI and advanced modeling

Fully synthetic, privacy-safe,
and validated for global collaboration

Supports reproducible
experiments with tracking

Adapts to research needs,
from simulation to validation

æqualis® is looking for visionary partners — from research labs to academic consortia — who believe that ethical, scalable, and innovative data can shape the next frontier of discovery